Reasons Why Post-Trial Access to Trial Drugs Should, or Need not be Ensured to Research Participants: A Systematic Review
Supplementary Data
files
Files in this Data Supplement:
Supplementary Data
- docx file
Supplementary Data
- docx file
Supplementary Data
- doc file